ARCHIVES

ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

June 5, 2009

Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses

June 13, 1986

Velcade Improves Survival In Relapsed Multiple Myeloma

July 29, 2005

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

Give New Investigators “Special Consideration,” Advisors Tell NCI

June 28, 2002

Tumor Classification, Monoclonal Antibody Announcements Made

January 7, 1983